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Abstract
Rapid reorganization of the actin cytoskeleton in response to receptor-mediated signal-
ing cascades allows platelets to transition from a discoid shape to a flat spread shape
upon adhesion to damaged vessel walls. Coronins are conserved regulators of the actin
cytoskeleton turnover but they also participate in signaling events. To gain a better
picture of their functions in platelets we have undertaken a biochemical and immuno-
cytochemical investigation with a focus on Coro1. We found that class I coronins Coro1,
2 and 3 are abundant in human and mouse platelets whereas little Coro7 can be
detected. Coro1 is mainly cytosolic, but a significant amount associates with membranes
in an actin-independent manner and does not translocate from or to the membrane
fraction upon exposure to thrombin, collagen or prostacyclin. Coro1 rapidly translocates
to the Triton insoluble cytoskeleton upon platelet stimulation with thrombin or collagen.
Coro1, 2 and 3 show a diffuse cytoplasmic localization with discontinuous accumulation
at the cell cortex and actin nodules of human platelets, where all three coronins
colocalize. Our data are consistent with a role of coronins as integrators of extracellular
signals with actin remodeling and suggests a high extent of functional overlap among
class I coronins in platelets.
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Introduction
Platelets are anucleate fragments of megakaryocytes that play pivotal
roles in hemostasis, thrombosis, wound healing and immunological
processes. Platelets display a remarkable morphological plasticity.
While in circulation they have a characteristic discoid shape, but are
capable of undergoing profound changes upon adhesion to damaged
blood vessel walls, transitioning to a spherical shape that extends
filopodia and lamellipodia as the cell spreads and flattens [1]. This
process is accompanied by secretion of granules and activation of
integrins that support and consolidate the formation of a platelet
aggregate. Remodeling of the cytoskeleton, formed by a network of
actin filaments and a marginal ring of microtubules and associated
proteins constitutes a crucial aspect of platelet function and is the
result of multiple exquisitely integrated signaling cascades [2].
A plethora of proteins with various biochemical activities is respon-
sible for the dynamics of actin remodeling during platelet activation,
including actin nucleators like formins and the Arp2/3 complex and
their regulators (WAVE, WASP), monomeric actin-binding proteins
like profilin, β-thymosin and the cyclase-associated protein (CAP) and
others like gelsolin, cofilin, and coronins [3–5].
Coronins constitute a family of conserved regulators of the actin
cytoskeleton turnover. The defining architectural element of this
family is the WD40 repeat that folds in a β-propeller structure and
characteristically participates in protein–protein interactions [6]. The
β-propeller is flanked by short highly conserved extensions. The
C-terminal extension is followed by a variable unique region and
a coiled-coil domain, and the latter involved in oligomerization [7,8].
Mammals express seven coronins that have been grouped into three
classes [9,10]. Among class I coronins (Coro1, 2, 3 and 6), Coro1 is
the most widely studied for its role in coordinating actin dynamics
through modulation of Arp2/3 complex and cofilin function [11].
Coro1 also plays less well-understood roles in NADPH oxidase
complex regulation, calcium release, vesicle trafficking and apopto-
sis [12–15]. Class I coronins localize at the leading edge ofmigrating
cells and to phagosomes in neutrophils [7,15,16]. Class II coronins
(Coro4 and 5) are involved in focal adhesion turnover, reorganization
of the cytoskeleton and cell migration [17,18]. The class III coronin
(Coro7) has an unusual structure, as it consists of two coronin blocks
in tandem and lacks a coiled-coil region. This atypical coronin plays
a role in Golgi morphology maintenance and does not appear to
participate in actin-related processes [19].
While coronins have been widely investigated in a variety of
cell types, very little is known about these proteins in platelets.
A recent report investigating the role of Coro1 in platelet
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function using a knockout mouse model revealed impaired
agonist-induced actin polymerization and cofilin phosphoregu-
lation and altered thrombus formation in vivo as salient phe-
notypes, in the absence of an overt hemostasis defect in vivo
[5]. This mild phenotype suggests a complex picture, with class
I coronins potentially sharing roles extensively in platelets.
We have undertaken a biochemical and immunocytochemical
investigation as an approach toward a clearer picture of the functions
of coronins in platelets. We show that class I coronins are abundant
in human and mouse platelets whereas little Coro7 can be detected.
Coro1 is mainly cytosolic, but a significant amount associates with
membranes in an actin-independent manner and does not translocate
from or to the membrane fraction upon platelet stimulation. In
immunocytochemistry studies, Coro1, 2 and 3 show a diffuse cyto-
plasmic localization with accumulation at the cell cortex and actin
nodules, where all three coronins colocalize. Our study strengthens
the view of complex redundancy among coronins in platelets, an
aspect to take into consideration in future functional studies.
Materials and Methods
Reagents
Primary antibodies against following proteins were used: Coro1
(ab56820 and ab72212), Coro2 (ab99407), CAP1 (ab133655), β-
actin (ab20272) fromAbcam (Cambridge,UK);Coro3 (K6-444hybri-
doma supernatant) [7], Coro7 (K37-142-1 hybridoma supernatant)
[20]; CD36 (H-300 sc-9154), Syk (4D10 sc-1240), β3-integrin
(HC93 sc-14009) and Gαs (sc-823) from Santa Cruz Biotechnology
(Heidelberg, Germany); cofilin (D3F9 #5175), profilin-1 (#3237),
phosphor-VASP (Ser157) (#3111) and phosphor-MLC (Ser19)
(#3671) from Cell Signaling Technology (Leiden, The Netherlands);
α-tubulin (05–829) and GAPDH (6C5-CB1001) from Calbiochem/
Merck (Watford, UK); p34-Arc/ARPC2 (07–227) from Millipore/
Merck; vinculin (SAB4200080) from Sigma/Merck; Myc, mouse
monoclonal 9E10 (kind gift of Angelika A. Noegel, University of
Cologne, Germany). Specificity of antibodies raised against Coro1,
Coro2 and Coro3 was tested on recombinantly expressed proteins in
HEK 293T cell lysates (Supplemental Figure 1)
Secondary antibodies Alexa Fluor 568- or 488-conjugated anti-
mouse and anti-rabbit immunoglobulins (Molecular Probes,
Thermo Fisher Scientific, Altrincham, UK) were used for immu-
nofluorescence. Peroxidase-conjugated anti-mouse and anti-rabbit
immunoglobulins (Merck) or IRDye 680 or IRDye 800 anti-mouse
and anti-rabbit immunoglobulins (LI-COR Biosciences, Lincoln,
USA) were used for Western blot.
Human fibrinogen was from Enzyme Research (Swansea, UK),
collagen (Kollagenreagens Horm) was from Takeda (Osaka, Japan),
latrunculin B was from Enzo Life Sciences (Exeter, UK), nocodazole
and CK-666 were from Tocris Bioscience (Abingdon, UK). PGI2 was
from Cayman Chemical (Michigan, USA). Thrombin, FITC or
TRITC-conjugated phalloidin were from Merck. Alexa Fluor 680-
conjugated phalloidin was from Thermo Fisher Scientific. Other
reagents were from Merck unless otherwise indicated.
Human Platelet Preparation
Human blood was taken from drug-free volunteers by clean vene-
puncture into acid citrate dextrose (ACD) (29.9 mM trisodium
citrate, 113.8 mM glucose, 72.6 mM NaCl and 2.9 mM citric acid,
pH 6.4). Platelet-rich plasma (PRP) was obtained by centrifugation
of whole blood at 190 × g for 15 min at room temperature. Platelets
were isolated fromPRP by centrifugation at 800 × g for 12min in the
presence of 6 mM citric acid. Platelets were washed in pH 6.5 buffer
(0.036M citric acid, 0.01M EDTA, 0.005M glucose, 0.005MKCl,
0.09 M NaCl) and centrifuged at 800 × g for 12 min. Sedimented
platelets were resuspended in modified Tyrode’s buffer (150 mM
NaCl, 5 mM HEPES, 0.55 mM NaH2PO4, 7 mM NaHCO3, 2.7 mM
KCl, 0.5 mMMgCl2, and 5.6 mM glucose, pH 7.4) and maintained
at 37°C for 30 min prior to experiments. The study was approved by
the Hull York Medical School Research Ethics Committee and all
research was performed in accordance with relevant guidelines and
regulations. Informed consent was obtained from all blood donors.
Mouse Platelet Preparation
Blood was taken by cardiac puncture into ACD, centrifuged at 100 ×
g for 5 min and the PRP was collected in a separate tube. Modified
Tyrode’s buffer was added to the blood and the procedure repeated to
increase the platelet yield. The platelets were then pelleted at 800 ×
g for 6 min, resuspended in modified Tyrode’s buffer andmaintained
at 37°C for 30 min prior to experiments.
Platelet Fractionation
Washed platelet suspensions (5 × 108 platelets/ml), either untreated
or treated with various substances for the appropriate time, were
mixed with an equal volume of fractionation buffer (320 mM
sucrose, 4 mM HEPES, 0.5 mM Na3VO4, pH 7.4) supplemented
with phosphatase and protease inhibitor cocktail. Latrunculin
B (LatB) was used at 20 µM for 20 min to depolymerize F-actin
prior to lysis. Samples were subjected to five freeze-thaw cycles in
liquid nitrogen. Intact platelets were removed by centrifugation at
1,000 × g for 5 min at 4°C and fractionationwas done by centrifuga-
tion at 100,000 × g for 60min at 4°C. The fractions were normalized
by volume and analyzed by Western blot.
Detergent-Insoluble Pellet Extraction
Washed platelet suspensions (1 × 109 platelets/ml) were lysed in
an equal volume of Triton X-100 containing lysis buffer (2%
Triton X-100, 10 mM Tris-HCl, 10 mM EGTA, pH 7.4) supple-
mented with protease inhibitors. Lysates were spun at 15,600 ×
g for 20 min (low speed) or 100,000 × g for 1 h (high speed) to
separate the detergent soluble fraction from the detergent-insolu-
ble pellet. The fractions were normalized by volume, resolved on
10% SDS-PAGE and analyzed by Western blot.
Immunoprecipitation
Platelets (1x109/ml) were lysed with one volume of lysis buffer
(20 mM HEPES, 30 mM NaCl, 0.3 mM EDTA, 2% n-dodecyl β-
D-maltoside, 0.5 mM DTT, pH 7.4) supplemented with protease
inhibitors for 30 min on ice. Two hundred to five hundred micro-
grams per milliliter of protein lysate were incubated overnight
with gentle rotation at 4°C with 1 μg of specific antibody or same
species control immunoglobulin. Twenty microliters of pre-equi-
librated protein G Sepharose beads were added to lysate-antibody
mixture and incubated at 4°C for 1 h. After several washing steps
with TBS-T (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20,
pH 7.4) the beads were resuspended in 2× Laemmli buffer and
immunocomplexes analyzed by Western blot.
Western Blot
Proteins were resolved by SDS-polyacrylamide gel electrophoresis
(PAGE) and blotted onto polyvinylidene difluoride (PVDF) mem-
brane. The membrane was incubated with the relevant primary anti-
body and either the corresponding peroxidase-conjugated secondary
antibody followed by enhanced chemiluminescence detection (Pierce,
Thermo Fisher Scientific Inc.) or the corresponding fluorochrome-
labeled secondary antibody and visualized and quantified with an LI-
COR Odyssey CLx Imaging System (LI-COR Biosciences,
Lincoln, USA).
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Immunostaining and Microscopy
Washed platelets in suspension were fixed with an equal volume of
ice-cold 4% paraformaldehyde (PFA) in PBS or, for tubulin staining,
3% PFA in 16 mM PIPES, 0.2 mM MgCl2, 0.2 mM EGTA, pH 6.8
and spun at 350 × g for 10 min on poly-L-lysine (0.01% in PBS)
coated coverslips. For adhesion studies, coverslips were coated over-
night at 4°C with 100 µg/ml fibrinogen or collagen and blocked with
heat-denatured fatty-acid-free bovine serum albumin for 1 h before
the experiment. Washed platelets were allowed to spread for 45 min
at 37°C, then fixedwith 4% PFA. Fixed platelets were permeabilized
Figure 1. Coronins present in human and mouse platelets and subcellular distribution of human Coro1. (A) Western blot of human and mouse platelet
lysates. Twenty micrograms of protein were resolved by 10% SDS-PAGE, blotted onto PVDF membrane and probed with antibodies for the indicated
proteins. The mouse Coro2 blot corresponds to a higher exposure than the human one. The Coro7 blot was enhanced to make the human protein
apparent (see Supplemental Figure 2 for details). GAPDH was used as a loading control. (B) Subcellular fractionation. Human platelets were lysed by
freeze-thaw in liquid nitrogen and spun at 100,000 × g for 1 h to separate membrane (M) and cytosolic (C) fractions. The fractions were normalized by
volume and resolved by 12% SDS-PAGE, blotted onto PVDF membrane and probed with antibodies for the indicated proteins. CD36 was used as
a membrane marker and Syk as a cytosolic marker in resting platelets. Latrunculin B (LatB; 20 µM, 20 min) was used to depolymerize F-actin prior to
lysis. Coro1 and actin distribution were quantified by densitometry and expressed as a percentage relative to the respective totals (M + C). (C)
Association of Coro1 to actin in the detergent-insoluble pellet. Human platelets (8 × 108/ml) were lysed in the presence of 1% Triton X-100 and lysates
spun at low speed (15,600 × g) for 20 min and high speed (100,000 × g) for 1 h. Supernatant (S) and pellet (P) fractions were normalized by volume
and resolved by 12% SDS-PAGE, blotted onto PVDF membrane and probed with antibodies for the indicated proteins. LatB (20 µM, 20 min) was used
to depolymerize F-actin prior to lysis. Coro1 and actin distribution in pellet and supernatant were quantified by densitometry and expressed as
a percentage of the respective total (P + S). Data of B and C represent mean ± SD of three independent experiments. **P< .01, ***P < .001 vs LatB-
treated, Student’s t-test.
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with 0.3% Triton® X-100 in PBS for 5 min and stained for 1 h at
room temperaturewith the indicated primary antibodies followed the
corresponding secondary antibodies and/or fluorescently labeled
phalloidin diluted in PBG (0.5% BSA, 0.05% fish gelatin in PBS).
Platelets were imaged by fluorescence microscopy using a Zeiss
ApoTome.2 equipped with AxioCam 506 and Zeiss Plan-
Apochromat 63×/1.4 and 100×/1.4 oil immersion objectives.
Images were processed with Zeiss Zen software.
Statistical Analysis
Experimental data were analyzed by GraphPad Prism v6.0 (La
Jolla, CA, USA). Data are presented as means ± standard error of
the mean (SEM) or standard deviation (SD) of at least three
independent experiments. Normality was assessed by the
Shapiro-Wilk test. Differences between groups were assessed
using the Student’s t-test, Mann-Whitney U-test, Wilcoxon test,
analysis of variance (ANOVA) or Kruskal-Wallis test and statis-
tical significance taken at p ≤ 0.05.
Results
Platelets Express at Least Four Coronins
Proteomics and transcriptomics studies indicate that both human and
mouse platelets express Coro1, 2, 3 and 7, while other coronins are
practically undetectable (Supplemental Table 1 and 2). To demon-
strate the presence of coronins in platelets we resolved human and
mouse platelet lysates by SDS-PAGE, followed by western blot with
a panel of antibodies specific for various coronins (see Supplemental
Figure 1 for antibody specificity). Coro1, 2 and 3 appeared as single
bands with apparent molecular weights of or above 56 kDa whereas
Coro7 appeared as a single band of 100 kDa (Figure 1A). While
Coro1, 2 and 3 appear relatively abundant, Coro 7 is expressed at
much lower levels in both human and mouse platelets. In this study
Figure 2. Subcellular localization of Coro1. Human platelets were fixed in suspension with paraformaldehyde and spun on poly-L-lysine coated
coverslips (A) or were allowed to spread on 100 µg/ml fibrinogen (B, D) or collagen (C) coated coverslips and fixed with paraformaldehyde. For A, B,
C and D cells were immunostained with an anti-Coro1 antibody followed by an Alexa568-coupled secondary antibody (red) and counterstained with
FITC-phalloidin for filamentous actin (green). For E platelets were treated with 100 nM PGI2 at 37°C 5 min prior to fixation in order to increase the
proportion of cells displaying actin nodules. Platelets were then immunostained with anti-Coro1 and anti-CAP1 antibodies followed by Alexa568 and
Alexa488-coupled secondary antibodies, respectively (red and green), and counterstained with Alexa680-phalloidin for filamentous actin (blue). Actin
color has been changed to red in the double staining panel with CAP1 for better visualization. Images were acquired with a fluorescence microscope
equipped with a structured illumination attachment and deconvolved. Magnified regions are indicated with a square. Arrows point at regions of
interest: cell cortex (A, B), actin filaments (C), actin nodules (D, E). Arrowheads in B point at Coro1 along stress fibers. Scale bars 5 µm. The scale bar
on A applies to B, C, and D.
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we will mainly focus on human Coro1 as a paradigm of class
I coronins, but will also address Coro3 and Coro2 is some assays
and will verify if our findings apply to mouse coronins.
Subcellular Distribution of Coro1
To investigate the distribution of Coro1 we carried out a simple
subcellular fractionation in human platelets. Resting platelets were
lysed in an isotonic sucrose solution and cytosol and membrane
fractions separated by ultracentrifugation and analyzed by immuno-
blot. As shown in Figure 1B, most of Coro1 (64%) was recovered in
the cytosolic fraction and the rest associated with the membrane
fraction. The blot was reprobed for β-actin and 77% of the actin was
cytosolic and the rest membrane-associated. Since Coro1 is an actin-
binding protein, we further investigated whether this membrane
association is mediated by actin. Resting platelets were treated
with 20 μM latrunculin B (LatB) to depolymerize F-actin prior to
subcellular fractionation. As expected, under these conditions
almost all actin was recovered in the cytosolic fraction. There was
no statistically significant difference in Coro1 association to the
membrane fraction in the absence (35.7 ± 9.6%) or presence (27.1
± 11.7%) of LatB, indicating that the association of Coro1 to platelet
membranes is independent of its association with actin. In these
experiments, probing for the cytosolic marker in resting platelets
spleen tyrosine kinase (Syk) and the membrane marker CD36 con-
firmed that each fractionation was free from cross-contamination.
We next characterized the association of Coro1 to the actin
cytoskeleton. Resting human platelets were lysed in the presence
of Triton X-100 and separated into soluble (containing G-actin)
and insoluble (containing F-actin) fractions by centrifugation at
low and high speeds followed by immunoblot analysis of the
fractions (Figure 1C)[21]. Under these conditions, actin is dis-
tributed as approximately 60% soluble and 40% insoluble. At low
speed, almost 60% of Coro1 was present in the Triton X-100
insoluble pellet, which contains large crosslinked actin filaments.
Treatment with LatB, which efficiently depolymerized actin fila-
ments, solubilized most of the Coro1, indicating that Coro1 in the
LS pellet is predominantly associated with F-actin.
At high speed nearly all the Coro1 was recovered in the Triton
X-100 insoluble pellet, which contains short actin filaments, even
upon treatment with LatB, indicating that the association of Coro1
to the HS pellet is independent of an association with short actin
filaments. We investigated the behavior of profilin and cofilin, two
proteins involved in actin filament turnover. Profilin was recovered in
the supernatants at both LS and HS, consistent with its role as mono-
meric actin-binding protein. Cofilin, which interacts with F-actin in
addition to G-actin, was observed in HS and LS pellets and was
removed from the LS pellet upon actin depolymerization, but not
completely from the HS pellet. Coro1, as well as part of cofilin,
may be associated with membranes or membrane proteins indepen-
dently of actin, as suggested by the presence of a fraction of the
membrane protein and lipid rafts component CD36 [22]. Syk was
used as Triton X-100 soluble fraction marker to confirm that isolation
of cytoskeleton fraction was clean.
To verify whether mouse Coro1 behaves similarly to
human Coro1, we carried out subcellular and Triton-X100
fractionations as above and observed a similar distribution in
membrane and cytosol fractions as well as in Triton-X100
supernatant and pellet fractions of mouse platelets
(Supplemental Figure 3A, B).
Localization of Coronins in Platelets
We used immunostaining and fluorescence microscopy to study the
distribution of Coro1, 2 and 3 in human andmouse platelets. In resting
platelets in suspension, which are predominantly discoid, the
distribution of Coro1 is punctate, very often accumulating at the cell
cortex, where it colocalizes with F-actin (Figure 2A). In platelets
spread on fibrinogen Coro1 displays a predominantly punctate diffuse
distribution, with frequent instances of discontinuous accumulation in
cortical regions, where the protein co-localizes with F-actin (Figure
2B, arrows). Under these conditions, Coro1 does not display a striking
pattern of association to stress fibers, although in some cases puncta
appear to align with stress fibers (Figure 2B, arrowheads). Platelets
spread on collagen fibers extend more broadly and present more
prominent stress fibers. Under these conditions we often see Coro1
accumulating along with thick actin cables in a discontinuous manner
(Figure 2C). Coro1 conspicuously accumulates at actin nodules
(Figure 2D), where it colocalizes with CAP1, which we have
described previously as a component of actin nodules (4). Both
Coro1 and CAP1 display a broad pattern of accumulation compared
to the sharper pattern of F-actin (Figure 2E).
Coronins have been proposed as organizers of the actin, microtu-
bule and intermediate filament systems [23].We investigated the effect
of disrupting the actin or microtubule cytoskeletons on Coro1 locali-
zation in platelets in suspension (Figure 3). LatB treatment resulted in
almost complete disappearance of filamentous actin and loss of Coro1
cortical accumulation while the microtubule ring was intact. By con-
trast, treatment with the microtubule depolymerizing drug nocodazole
resulted in the dispersal of the microtubule ring but intact cortical
accumulation of Coro1 and actin. This indicates that Coro1 accumula-
tion at the platelet cortex is primarily dependent on F-actin.
Coro2 and Coro3 display patterns of localization very
similar to Coro1. In platelets, in suspension, both proteins
show a punctate pattern, often enriched at the cell cortex and
colocalizing with F-actin (Figure 4A, D). When spread on
fibrinogen the pattern of localization of Coro2 and Coro3
was relatively uniformly dotty, with frequent discontinuous
accumulation at the cell cortex (Figure 4B, E). This pattern
of cortical enrichment was less apparent with Coro2, which
in general gave an overall weaker staining than Coro3. Both
coronins also accumulated and colocalized with F-actin at
actin nodules (Figure 4C, F). Taking into account the weaker
staining of Coro2, its accumulation at actin nodules appeared
relatively more intense than that of Coro3.
In mouse platelets spread on fibrinogen the localization of
Coro1, 2 and 3 resembled that of the respective human counter-
part, with a predominantly punctate pattern and frequent discon-
tinuous accumulation and colocalization with F-actin at the cortex
(Supplemental Figure 3C).
Class I Coronins Co-immunoprecipitate and Colocalize in
Platelets
Coro1 has been reported to interact with the Gαs subunit of
heterotrimeric G proteins and stimulate the cAMP/PKA pathway
in murine excitatory neurons and loss of Coro1 results in neuro-
behavioral defects [24]. To explore whether this interaction repro-
duces in platelets we performed immunoprecipitation experiments
in human platelet lysates and found that Coro1 is able to co-
immunoprecipitate Gαs (Figure 5A, upper panel). Upon co-
immunoprecipitation of Coro2, Gαs was also retrieved in the
immunocomplexes along with Coro3 (Figure 5A, lower panel).
In support of Gαs forming complexes with coronins, we immu-
nostained platelets in suspension for Coro1 and Gαs. Coro1
showed the characteristic discontinuous cortical accumulation,
whereas the distribution of Gαs was punctate and uniform. We
observed, however, instances of co-localization of both proteins at
the cell cortex (Figure 5B). In these experiments, ARPC2,
a subunit of the Arp2/3 complex, was found in the immunocom-
plexes and partially colocalizing with Coro1 at the cell cortex of
spread platelets, compatible with the already reported interaction
DOI: https://doi.org/10.1080/09537104.2019.1696457 Platelet coronins 5
of the Arp2/3 complex with class I coronins (Figure 5B) [25–27].
To further investigate this colocalization we studied the effect of
inhibiting the Arp2/3 complex on Coro1 localization
(Supplemental Figure 4). We treated platelets with the Arp2/3
complex inhibitor CK-666 at a range of concentrations spanning
three orders of magnitude (0.5, 5 and 50 µM), stimulated them
with thrombin and allowed them to spread on fibrinogen for 45
min. Without thrombin stimulation, most untreated platelets
Figure 3. Subcellular localization of Coro1 upon disruption of the actin and tubulin cytoskeletons. Human platelets were incubated with 3 µM LatB or
10 µM nocodazole for 30 min, fixed in suspension with paraformaldehyde and spun on poly-L-lysine coated coverslips. Cells were immunostained with
anti-Coro1 and anti-tubulin antibodies followed by Alexa568 and Alexa488-coupled secondary antibodies, respectively (red and green), and counter-
stained with Alexa680-phalloidin for filamentous actin (blue). Images were acquired with a fluorescence microscope equipped with a structured
illumination attachment and deconvolved. Arrows indicate the magnified cell shown in the second row of each treatment. Scale bar 5 µm.
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adopted a spiky morphology with numerous actin nodules but
responded to thrombin with an extended round morphology and
clear enrichment of ARPC2 at the cortex, with Coro1 often
accumulating at the cortex too. The lower concentration of CK-
666 had little effect on ARPC2 and Coro1 localization. Increasing
concentrations of the inhibitor resulted in a high proportion of
non-spread round platelets in the absence of thrombin stimulation,
however the cells responded to thrombin. While 5 µM CK-666
still resulted in round well-spread platelets, with 50 µM CK-666
most platelets adopted an irregular shape with a few filopods,
consistent with the inhibited formation of lamellipodia [28]. The
cortical accumulation of ARPC2 persisted upon treatment with
CK-666, consistent with the fact that CK-666 stabilizes the inac-
tive state of the Arp2/3 complex, but does not prevent its binding
to actin filaments [29], however Coro1 cortical accumulation was
largely lost.
The similar patterns of subcellular localization of all three
class I coronins suggest that they might be performing similar
functions and may co-localize and participate in complexes with
each other. In fact, as indicated above, Coro2 and Coro3 co-
immunoprecipitate. To investigate the extent of co-localization
of the three-class I coronins in platelets we performed
a combination of double stainings (Figure 5C). These studies
revealed that while all three coronins accumulate at the cell
Figure 4. Subcellular localization of Coro2 and 3. Human platelets were fixed in suspension with paraformaldehyde and spun on poly-L-lysine coated
coverslips (A, D) or were allowed to spread on 100 µg/ml fibrinogen coated coverslips (B, E, C, F) and fixed with paraformaldehyde. Cells were
immunostained with an anti-Coro2 or Coro3 antibody followed by an Alexa568-coupled secondary antibody (red) and counterstained with FITC-
phalloidin for filamentous actin (green). Images were acquired with a fluorescence microscope equipped with a structured illumination attachment and
deconvolved. Magnified regions are indicated with a square. Arrows point at regions of interest: cell cortex (A, B, D, E), actin nodules (C, F). Scale bar
5 µm.
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Figure 5. Coronins exist in complexes with each other and with Gαs and the Arp2/3 complex. (A) Human platelet lysates were subject to
immunoprecipitation with Coro1 or Coro2-specific antibodies. The same species of the total immunoglobulin G (IgG) was used as a control.
Protein complexes were examined by Western blot for the presence of the indicated proteins. (B) Colocalization of Coro1 with Gαs and ARPC2. For
Gαs platelets were fixed in suspension with paraformaldehyde and spun on poly-L-lysine coated coverslips. For ARPC2 platelets were allowed to
spread on 100 µg/ml fibrinogen coated coverslips and fixed with paraformaldehyde. Cells were immunostained with anti-Coro1 and anti-ARPC2 or
anti-Gαs antibody followed by Alexa568 or Alexa488-coupled secondary antibodies, respectively (red and green). Images were acquired with
a fluorescence microscope equipped with a structured illumination attachment and deconvolved. Arrows point at regions of apparent colocalization.
Scale bar 5 µm. (C) Coronins colocalize with each other. Platelets were allowed to spread on 100 µg/ml fibrinogen coated coverslips, fixed with
paraformaldehyde, immunostained with the indicated coronin antibodies followed by Alexa568 or Alexa488-coupled secondary antibodies, respec-
tively (red and green), and counterstained with Alexa680-phalloidin for filamentous actin (blue). Images were acquired as in (B). Arrows point at
regions of interest: cell cortex (upper panels), actin nodules (lower panels). Scale bar 5 µm.
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cortex, some extent of co-localization was apparent in all combi-
nations, although in the case of Coro1 and Coro3 colocalization
seemed clearer. A clear pattern of colocalization was observed in
actin nodules in every combination of coronin immunostainings.
Translocation of Coronins upon Platelet Stimulation
Stimulation with strong agonists typically provokes a rapid increase
in actin polymerization that can be monitored on time by analyzing
the amount of actin in the LS detergent-insoluble pellet. Both upon
thrombin and collagen stimulation the proportion of actin in the LS
pellet rapidly increased to a twofold peak at 60 s and remained
elevated afterward (Figure 6). We explored the effect of those
agonists in the association of Coro1 and 3 to the LS pellet.
Platelets were stimulated with 0.1 U/ml thrombin or 50 μg/ml
collagen and the reaction was stopped with lysis buffer at various
time points up to 3 min. We observed a statistically significant time-
dependent increase in the proportion of both Coro1 and 3 in the LS
pellet that roughly paralleled that of actin (Figure 6). In mouse
platelets both actin and Coro1 behaved similarly to their human
counterparts in response to thrombin and collagen, although Coro1
appeared to peak earlier (at 15 s) (Supplemental Figure 3D).
As shown above, one-third of Coro1 is membrane associated. To
investigate whether exposure to various stimuli would affect this
pattern of distribution we treated platelets in suspension with 0.1 U/
ml thrombin, 50 μg/ml collagen or 100 nMPGI2 and subjected them
to subcellular fractionation followed by Western blot analysis. We
did not observe any significant change in the proportion of Coro1 or
Coro3 upon any of the treatments (Figure 7).
Discussion
In this study, we present immunological evidence of the presence
of members of the coronin family in human and mouse platelets.
We show that class I coronins Coro1, 2 and 3 are abundant in
platelets from both species, whereas expression of Coro7 is com-
paratively very low. Our results are in very broad agreement with
data from proteomics and transcriptomic studies (Supplemental
Table 1 and 2), with the caveat that western immunoblot results
are not suitable for quantitative comparisons due to the fact that
all the antibodies we have used were raised against fragments of
human coronins; therefore, we expect them to have different
affinities for the corresponding mouse protein. In addition, the
affinities of the antibodies are also expected to vary among the
different coronins of the same species.
At 53,600 copies per platelet, class I coronins taken together are
among the most abundant proteins in human platelets [30], and
appear to be approximately 2.5 times more abundant in mouse
platelets [31]. Coro2 exists in less copies per platelet than Coro1
and 3 in both human and mouse, which might explain the weaker
signal we usually observe in immunostainings for this coronin.
While Coro1 and 3 are present in similar copy numbers in human
platelets, Coro1 is considerably more abundant than Coro3 in mouse
platelets [30,31]. Interestingly, proteomics and transcriptomics stu-
dies reveal a lack of correlation of protein and transcript levels:
Coro3 mRNAs are present at considerably high levels in human
platelets, whereas Coro1 mRNAs are present at very low levels in
mouse platelets [32].
Coro7 is the least abundant coronin in platelets, with an
estimated 760 and 3571 copies in human and mouse platelets,
respectively [30]. Our western blot data clearly reflect this differ-
ence in abundance between species. Some proteomics and tran-
scriptomics studies fail to identify Coro7, probably due to
technical limitations [33,34], or to expression lying below the
cutoff set for a gene to be included in the list of expressed
genes [35,36]. A significant proportion of Coro7 associates with
Golgi membranes [19,20]. Usually, very little Golgi is present in
mature platelets, explaining the relatively very low abundance of
this isoform, which we speculate might have a role in platelet
maturation by regulating Golgi-related processes. Based on tran-
scriptomics studies, Coro4, 5 and 6 do not appear to be expressed
to significant levels in human and mouse platelets and conse-
quently remain undetectable in proteomics studies (Supplemental
Table 1 and 2).
In platelets, approximately 36% of Coro1 is recovered in the
membrane fraction and this association is independent of the actin
cytoskeleton, as indicated by its persistence after LatB treatment.
This is in broad agreement with a study in J774 macrophages,
where Gatfield et al. found 20% of Coro1 associated with mem-
branes [8]. Also, 40% of Coro3 had previously been found asso-
ciated with membranes [7]. We are not aware of any study that
formally addresses the subcellular distribution of Coro2, but this
coronin is required for endosome fission, therefore some extent of
membrane association is expected [37]. Membrane association
has been reported for the Plasmodium falciparum homolog too
[38,39], and therefore seems to be a common feature of coronins.
Several mechanisms might account for the membrane association
of coronins, most notably their ability to directly bind PI(4,5)P2
[39,40], but interactions with other membrane-associated proteins
are also likely to contribute, for example, Rac1 and Gαs with
Coro1 and Rab27a with Coro3 [24,41,42]. None of the stimuli we
have tested in platelets produces a noticeable translocation of
Coro1 or 3 between the membrane fraction and the cytosol,
suggesting that either translocation is not required for coronin
function or the amount that translocates is below the levels
detectable with our techniques.
Figure 6. Dynamics of Coro1 along with F-actin in the Triton X-100 insoluble pellet of platelets stimulated with thrombin or collagen. Washed human
platelets were stimulated with thrombin (0.1 U/ml) or collagen (50 µg/ml) at the indicated time points and lysed immediately in 1% Triton X-100 lysis
buffer. Triton insoluble pellets were prepared by low-speed centrifugation (15,600 × g for 15 at 4°C), run on SDS-PAGE and subjected to Western blot
analysis with anti-Coro1, Coro3 and β-actin antibodies. Densitometry values are expressed as means ± SEM of 3–7 experiments *P < .05, **P< .01,
***P < .001 relative to basal, student’s t-test.
DOI: https://doi.org/10.1080/09537104.2019.1696457 Platelet coronins 9
Sixty percent of the Coro1 fractionates in the LS detergent-
insoluble pellet of platelets, predominantly associated with F-actin.
A similar behavior has been described for this coronin in J774
macrophages [8]. The proportion of Coro1 in the LS pellet increases
rapidly upon stimulation with strong agonists and Coro3 shows
a comparable behavior, consistent with the role of class I coronins
in actin filament remodeling in platelets. By contrast, virtually all the
Coro1 was recovered in the HS pellet of platelets and this association
was not disrupted by LatB, indicating that it is independent of actin.
This may represent Coro1 associated with membrane-containing
structures like lipid rafts, along with a fraction of cofilin. Coro3
too has been reported as abundant in the HS pellet of HaCat cells,
from where it is partially extracted in the presence of LatB [26].
Coro1, 2 and 3 display a similar localization in human platelets,
with a diffuse punctate cytoplasmic localization and a discontinuous
enrichment at the cortex of both suspended and spread platelets,
where it co-localizes with F-actin and, in the latter, the Arp2/3
complex. This pattern is similar to the reported localization of
Coro1 in macrophages and lymphocytes, [8,13,43,44] as well as in
unicellular organisms like Dictyostelium discoideum, Trichomonas
vaginalis and Plasmodium falciparum [39,45,46], but Coro1 is also
recruited at phagosomes in macrophages and neutrophils [27,43].
Coro2 and 3 have been shown to display a diffuse cytosolic
localization with enrichment at peripheral protrusions in a variety
of cells, like DRG neurons, lung endothelial cells, fibroblasts, HEK
cells, oligodendrocytes, HaCat cells, and Pop10 hepatocarcinoma
cells [7,25,26,47–49]. The accumulation of Coro1 at the cell cortex
seems to be dependent on the activity of the Arp2/3 complex and is
evident only in spread platelets morphologically compatible with the
presence of lamellipods. We observed Coro1 localizing in
a discontinuous pattern at stress fibers, more clearly in platelets
spread on collagen, a matrix protein that usually leads to the forma-
tion of more robust actin cables compared to fibrinogen.
Localization of class I coronins at stress fibers has been very seldom
reported and might indicate sites of active remodeling under specific
circumstances [23]. Mouse class I coronins showed a pattern of
predominantly diffused cytoplasmic distribution with some cortical
accumulation, similar to their human counterparts and in agreement
with a recent report that addressed the immunolocalization of Coro1
in mouse platelets [5].
A localization of class I coronins in actin nodules has not been
reported before. These podosome-related structures consist of a core
rich in actin and Arp2/3 complex core surrounded by a ring rich in
focal adhesion molecules like talin and vinculin [50]. They are
usually visible during early adhesion and spreading [51]. We have
recently shown that CAP1, a protein involved in recycling of actin
Figure 7. Coronins do not translocate upon platelet stimulation. (A) Washed human platelets (8 × 108/ml) were treated with 1 mM EGTA, 10 nM
indomethacin and 2 U/ml apyrase for 20 min at 37°C to prevent aggregation. They were then treated with 0.1 U/ml thrombin, 50 µg/ml collagen or 100
nM PGI2 for 1 min at 37°C prior to lysis and subcellular fractionation. Fractions were normalized by volume and resolved on 12% SDS-PAGE, blotted
onto PVDF membrane and probed with antibodies for Coro1 and Coro3. Integrin β3 was used as a membrane marker and GAPDH as a cytosolic
marker. The phosphoproteins pMLC-S19 and pVASP-S157 were used as markers of the effects of thrombin/collagen and PGI2, respectively, and
GAPDH as a loading control. (B) Membrane-associated Coro1 and Coro3 upon stimulation were quantified by densitometry, normalized to integrin β3
and expressed relative to the respective coronin in the basal membrane fraction. Data represent the mean ± SEM of 3–6 independent experiments. No
statistically significant differences were found relative to basal for any coronin using Mann-Whitney U and Kruskal-Wallis tests.
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monomers, is also a component of the actin nodule ring [4], therefore
we speculate that coronins too might contribute to the actin filament
turnover of these highly dynamic structures.
Class I coronins are reported to exist as homo-oligomers and
there is no evidence for the formation of hetero-oligomers [7,8,25].
The colocalization of class I coronins to the same structures in
platelets suggests that theymight be part of large complexes contain-
ing more than one isoform, as demonstrated by the ability of Coro2
to co-immunoprecipitate Coro3. This is in contrast to the report of
Cai et al. (2005) that failed to observe a co-immunoprecipitation of
Coro2 with any other coronin in a fibroblast cell line [25], however
large-scale interactome studies have identified class I coronins as
part of the same complexes [52,53].
In summary, we provide evidence that class I coronins are
abundant cytoskeleton regulators in platelets, where they may
play roles in organizing the cortical cytoskeleton upon adhesion
and spreading, consistent with the emerging role of coronins as
integrators of extracellular signals with actin remodeling. The fact
that class I coronins co-localize and different isoforms might
participate in the same complex strongly suggests a high extent
of functional overlap and would explain the mild phenotype of
platelets lacking Coro1 [5]. Functional overlap is expected to
occur in most white blood cell types, where all three class
I coronins appear to be expressed simultaneously (Supplemental
Figure 5). Further studies on animal models lacking one or more
class I coronins will be required to elucidate the unique and
shared roles of these proteins in platelet function.
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